This study investigated the expression and prognostic implications of C‐X‐C chemokine receptor type 5 (CXCR5) and lymphocyte activation gene‐3 (LAG‐3) on peripheral blood CD8+ T cells in patients with DLBCL. This evidence concerns the gene CXCR5 and diffuse large B-cell lymphoma.